Joerg H.O. Garbe

752 total citations
9 papers, 612 citations indexed

About

Joerg H.O. Garbe is a scholar working on Immunology and Allergy, Molecular Biology and Cell Biology. According to data from OpenAlex, Joerg H.O. Garbe has authored 9 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology and Allergy, 3 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in Joerg H.O. Garbe's work include Cell Adhesion Molecules Research (4 papers), Intellectual Property and Patents (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Joerg H.O. Garbe is often cited by papers focused on Cell Adhesion Molecules Research (4 papers), Intellectual Property and Patents (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Joerg H.O. Garbe collaborates with scholars based in Switzerland, Germany and United States. Joerg H.O. Garbe's co-authors include Takako Sasaki, Rupert Timpl, Michael Wiggenhorn, Hanns‐Christian Mahler, Andrea Hawe, Wim Jiskoot, Marco van de Weert, Dessislava Markova, Douglas R. Keene and Franz‐Georg Hanisch and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Biochemical Journal.

In The Last Decade

Joerg H.O. Garbe

9 papers receiving 600 citations

Peers

Countries citing papers authored by Joerg H.O. Garbe

Since Specialization

Citations

This map shows the geographic impact of Joerg H.O. Garbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg H.O. Garbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg H.O. Garbe more than expected).

Fields of papers citing papers by Joerg H.O. Garbe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg H.O. Garbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg H.O. Garbe. The network helps show where Joerg H.O. Garbe may publish in the future.

Co-authorship network of co-authors of Joerg H.O. Garbe

This figure shows the co-authorship network connecting the top 25 collaborators of Joerg H.O. Garbe. A scholar is included among the top collaborators of Joerg H.O. Garbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg H.O. Garbe. Joerg H.O. Garbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Modern science for better quality control of medicinal products “Towards global harmonization of 3Rs in biologicals”: The report of an EPAA workshop 2017 ·Biologicals ·Katrin Schütte, (unknown), Marlies Halder, Klaus Cußler, Ursula G. Sauer, Catrina Stirling, (unknown), Iwona Wilk–Zasadna, David P. John, Martin Bopst, Joerg H.O. Garbe, Harrie L. Glansbeek, Robin Levis, (unknown), (unknown), Paul Stickings	21
2	Import Testing: An Outdated Practice? Opportunities for Improved Access to Safe and Efficient Medicines 2017 ·Therapeutic Innovation & Regulatory Science ·Joerg H.O. Garbe, (unknown), (unknown)	2
3	Import testing turned into an unnecessary limitation of patient access to medicines as risks are managed effectively 2016 ·Pharmaceuticals Policy and Law ·(unknown), Joerg H.O. Garbe	2
4	Historical Data Analyses and Scientific Knowledge Suggest Complete Removal of the Abnormal Toxicity Test as a Quality Control Test 2014 ·Journal of Pharmaceutical Sciences ·Joerg H.O. Garbe, (unknown), (unknown), Martin Bopst, (unknown), (unknown), (unknown), (unknown), (unknown), Natalia Semenova, (unknown), (unknown), (unknown), (unknown)	17
5	Forced Degradation of Therapeutic Proteins 2011 ·Journal of Pharmaceutical Sciences ·Andrea Hawe, Michael Wiggenhorn, Marco van de Weert, Joerg H.O. Garbe, Hanns‐Christian Mahler, Wim Jiskoot	201
6	A Comparative Analysis of the Fibulin Protein Family 2007 ·Journal of Biological Chemistry ·Naoyuki Kobayashi, Günter Kostka, Joerg H.O. Garbe, Douglas R. Keene, Hans Peter Bächinger, Franz‐Georg Hanisch, Dessislava Markova, Takeshi Tsuda, Rupert Timpl, Mon‐Li Chu, Takako Sasaki	217
7	Distinct Requirements for Heparin and α-Dystroglycan Binding Revealed by Structure-based Mutagenesis of the Laminin α2 LG4–LG5 Domain Pair 2003 ·Journal of Molecular Biology ·(unknown), Joerg H.O. Garbe, (unknown), Rupert Timpl, Takako Sasaki, Erhard Hohenester	64
8	Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin α3B and α5 chains 2002 ·Biochemical Journal ·Joerg H.O. Garbe, Walter Göhring, Karlheinz Mann, Rupert Timpl, Takako Sasaki	53
9	Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin α3B and α5 chains 2002 ·Biochemical Journal ·Joerg H.O. Garbe, Walter Göhring, Karlheinz Mann, Rupert Timpl, Takako Sasaki	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact